Taken together, these results demonstrate that FBXW2 inhibition of migration and invasion in lung cancer cells is mediated via promoting β-catenin degradation and consequent downregulation of MMP expression, which is preferentially regulated by the β-catenin-S552D-TCF4M/S transcription factors. Here, FBXW2 is linked to lung cancer.